SGLT2 Inhibitors and the Risk of Hospitalization for Fournier’s Gangrene: A Nested Case–Control Study

被引：0
|
作者：
Tongtong Wang
Shrita M. Patel
Anne Hickman
Xinyue Liu
Philip LStJ Jones
Ira Gantz
Carol E. Koro
机构：
[1] Merck & Co.,Department of Pharmacoepidemiology
[2] Inc.,Department of Clinical Safety and Risk Management
[3] Merck & Co.,Department of Global Clinical Development
[4] Inc.,Pharmaceutical Health Services Research, School of Pharmacy
[5] Safety Surveillance and Risk Management,undefined
[6] Pfizer Inc.,undefined
[7] Safety Surveillance and Risk Management,undefined
[8] Pfizer Inc.,undefined
[9] Merck & Co.,undefined
[10] Inc.,undefined
[11] University of Maryland,undefined
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Antihyperglycemic agents; Fournier’s gangrene; Nested case–control study; Sodium–glucose cotransporter 2 inhibitors (SGLT2i); Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：711 / 723
页数：12
相关论文
共 50 条
  • [1] SGLT2 Inhibitors and the Risk of Hospitalization for Fournier's Gangrene: A Nested Case-Control Study
    Wang, Tongtong
    Patel, Shrita M.
    Hickman, Anne
    Liu, Xinyue
    Jones, Philip L. St J.
    Gantz, Ira
    Koro, Carol E.
    DIABETES THERAPY, 2020, 11 (03) : 711 - 723
  • [2] Fournier's gangrene and SGLT2 inhibitors: A case study
    Garcia-Garcia, Alejandra
    Galeano-Valle, Francisco
    Antonio Nuevo-Gonzalez, Jose
    Pablo Demelo-Rodriguez, Y.
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2020, 67 (06): : 423 - 425
  • [3] Risk of Fournier's gangrene with SGLT2 inhibitors
    Reactions Weekly, 2019, 1738 (1) : 3 - 3
  • [4] FAERS analysis: Fournier gangrene with SGLT2 inhibitors
    Reactions Weekly, 2019, 1754 (1) : 8 - 8
  • [5] Fournier gangrene: new safety concern of SGLT2 inhibitors
    Reactions Weekly, 2019, 1753 (1) : 8 - 8
  • [6] SGLT-2 inhibitors increase risk of Fournier's gangrene, especially in male patients
    Reactions Weekly, 2022, 1896 (1) : 12 - 12
  • [7] Fournier gangrene with SGLT-2 inhibitors: administrative claims
    Reactions Weekly, 2019, 1771 (1) : 11 - 11
  • [8] Perspectives From a Regional Plastic Surgery Centre on Evidence for the Purported Link Between SGLT2 Inhibitors and Fournier's Gangrene
    Taylor, Luke
    Asmar, Omar
    Mandal, Anirban
    Tridente, Ascanio
    Hardy, Kevin
    Shokrollahi, Kayvan
    FRONTIERS IN SURGERY, 2021, 8
  • [9] SGLT2 inhibitors: risk of polycythaemia
    Reactions Weekly, 2023, 1961 (1) : 7 - 7
  • [10] Fournier's Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications
    Kasbawala, Kinjal
    Stamatiades, George A.
    Majumdar, Sachin K.
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : 1 - 4
12345